Chennai, Tamil Nadu – The Vellore Institute of Technology (VIT) Chennai, in collaboration with The Hindu, is hosting a significant Biotech Conclave today, September 10, 2026. This one-day event aims to provide a comprehensive platform for students, researchers, and industry professionals to explore the burgeoning opportunities and future trajectory of the life sciences sector. The conclave is designed to offer insights into the evolving role of biotechnology in addressing societal challenges and driving innovation.
Expert Dialogue on Biotechnology’s Future
The VIT Chennai–The Hindu Biotech Conclave 2026 brings together a distinguished panel of experts, industry leaders, and academicians. The event’s primary objective is to foster a dialogue on how biotechnology is shaping the future, with a particular focus on its impact on education, research, and enterprise. Information was available with The Chenab Times that the conclave is envisioned as a student-centric initiative, catering to higher secondary students, undergraduates, researchers, and aspiring biotechnology professionals.
The inauguration of the conclave was led by Suchitra Ella, the co-founder and managing director of Bharat Biotech and CII-president designate. Presiding over the event was G. Viswanathan, the founder and chancellor of Vellore Institute of Technology (VIT). G. V. Selvam, Vice-President of VIT, delivered a special address, emphasizing the transformative potential of biotechnology. He stated that biotechnology represents a critical frontier in education and research, offering solutions to pressing societal issues and serving as a pathway to innovation and meaningful contribution to humanity.
Student Engagement and Industry Insights
A key feature of the conclave is the direct interaction between students and prominent figures in the biotechnology field. Suchitra Ella engaged with participants, sharing her extensive experience as a leading entrepreneur in India’s biotechnology sector. This interactive session provided attendees with valuable insights into the practical aspects of the industry.
Further discussions included a panel featuring Ganapathy, honorary distinguished professor at IIM Jammu and distinguished professor at The Tamil Nadu Dr. M.G.R. Medical University; Mayur Abhaya, managing director of LifeCell International; and Shridevi S, deputy director at the Centre for NeuroInformatics, VIT Chennai. Moderated by Zubeda Hamid, senior assistant editor of The Hindu, the panel explored the convergence of technology and biotechnology. Another critical discussion focused on advancements in gene editing and precision medicine, delving into the latest developments in genomics.
Exploring Research and Innovation Ecosystems
The conclave also dedicated sessions to India’s broader research and innovation landscape. A notable session featured K. VijayRaghavan, from the National Centre for Biological Sciences, Tata Institute of Fundamental Research, in conversation with Jacob Koshy, Science Editor at The Hindu. Their discussion centered on the evolution of India’s research and innovation ecosystem, identifying key opportunities, and assessing its role in shaping the future of biotechnology and life sciences. This session aimed to provide a strategic perspective on the nation’s scientific endeavors and their global implications.
The VIT Chennai–The Hindu Biotech Conclave serves as a crucial platform for knowledge exchange, aiming to inspire the next generation of life science professionals and highlight the dynamic opportunities within the biotechnology sector. The event underscores the importance of interdisciplinary collaboration and cutting-edge research in driving progress and addressing future challenges.
❤️ Support Independent Journalism
Your contribution keeps our reporting free, fearless, and accessible to everyone.
Or make a one-time donation
Secure via Razorpay • 12 monthly payments • Cancel anytime before next cycle


(We don't allow anyone to copy content. For Copyright or Use of Content related questions, visit here.)

The Chenab Times News Desk



